Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...

At 12:40 p.m. Thursday, the National Weather Service issued the alert for Midland, Bay, Saginaw, Huron, Tuscola and Sanilac ...

During monsoon season, respiratory infections, allergies, and chronic respiratory disorders including asthma and chronic ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today topline results from the pivotal Phase ...

The Cambridge, England-based pharmaceutical company said the positive opinion from the Committee for Medicinal Products for Human Use endorses Trixeo Aerosphere, or ...

AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached ...

Cataracts are opacities of the lens of the eye and can lead to painless and progressive loss of visual acuity.

Anoro Ellipta is a brand-name prescription medication to manage chronic obstructive pulmonary disease (COPD) symptoms in adults. Common side effects of Anoro Ellipta are generally mild, but ...

Basel: Roche has announced topline results from the pivotal phase IIb ALIENTO (n=1,301) and the phase III ARNASA (n=1,375) ...